FIELD: medicine.
SUBSTANCE: invention refers to medicine. Described is a silicon-containing biologically degradable material for preventing and/or treating diseases, which are accompanied by low and/or disturbed angiogenesis, and/or diseases, a recovery of which requires an increase in angiogenesis.
EFFECT: silicon-containing biologically degradable material is applicable in higher dosage; it is degradable in a body, eg saved subcutaneously for a long period of time, and promote pro-angiogenic processes.
7 cl, 7 dwg, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SILICON-CONTAINING BIODEGRADABLE MATERIAL FOR ANTI-INFLAMMATORY THERAPY | 2011 |
|
RU2571504C2 |
| TREATING OCULAR DISEASES | 2007 |
|
RU2472523C2 |
| ANTIANGIOGENIC MEDICINAL AGENT AND METHOD OF ITS PRODUCTION | 2009 |
|
RU2404783C1 |
| PHARMACEUTICAL PREPARATION | 2009 |
|
RU2542512C2 |
| HUMAN PROTEIN TYROSINE PHOSPHATASE BETA BINDING ANTIBODIES (HPTPBETA), AND USE THEREOF | 2007 |
|
RU2494108C2 |
| APPLICATION OF EDG-RECEPTOR BINDING AGENT IN CANCER THERAPY | 2003 |
|
RU2358717C2 |
| SILICA SOL-BASED MATERIAL FOR PRODUCING BIOLOGICALLY DEGRADABLE AND/OR RESORBABLE SILICA GEL MATERIALS, PRODUCTION AND USE THEREOF | 2008 |
|
RU2460697C2 |
| ANTIANGIOGENIC DRUG | 2016 |
|
RU2634253C1 |
| COMPOSITIONS OF EXTRACELLULAR VESICLES (EV) OF PLANT ORIGIN AND THEIR USE | 2020 |
|
RU2812553C2 |
| EXTRACELLULAR VESICLES ORIGINATING FROM MESENCHYMAL STEM CELLS | 2019 |
|
RU2805066C2 |
